Back to SNDX
VANGUARD GROUP INC SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
20
Latest value
$116.1M
Q4 2025
Peak value
$116.1M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $184K |
| Q1 2025 | $443K |
| Q1 2025 | $959K |
| Q1 2025 | $737K |
| Q1 2025 | $57.5M |
| Q2 2025 | $183K |
| Q2 2025 | $338K |
| Q2 2025 | $746K |
| Q2 2025 | $488K |
| Q2 2025 | $45.4M |
| Q3 2025 | $802K |
| Q3 2025 | $555K |
| Q3 2025 | $68.7M |
| Q3 2025 | $301K |
| Q3 2025 | $8.7M |
| Q4 2025 | $411K |
| Q4 2025 | $786K |
| Q4 2025 | $12.5M |
| Q4 2025 | $1.1M |
| Q4 2025 | $116.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $116.1M | 5.53M | — | — |
| Q4 2025 | $1.1M | 52.1K | — | — |
| Q4 2025 | $12.5M | 593.9K | — | — |
| Q4 2025 | $786K | 37.4K | — | — |
| Q4 2025 | $411K | 19.6K | — | — |
| Q3 2025 | $8.7M | 562.7K | — | — |
| Q3 2025 | $301K | 19.6K | — | — |
| Q3 2025 | $68.7M | 4.47M | — | — |
| Q3 2025 | $555K | 36.0K | — | — |
| Q3 2025 | $802K | 52.1K | — | — |
| Q2 2025 | $45.4M | 4.85M | — | — |
| Q2 2025 | $488K | 52.1K | — | — |
| Q2 2025 | $746K | 79.7K | — | — |
| Q2 2025 | $338K | 36.0K | — | — |
| Q2 2025 | $183K | 19.6K | — | — |
| Q1 2025 | $57.5M | 4.68M | — | — |
| Q1 2025 | $737K | 60.0K | — | — |
| Q1 2025 | $959K | 78.1K | — | — |
| Q1 2025 | $443K | 36.0K | — | — |
| Q1 2025 | $184K | 15.0K | — | — |
Other funds holding SNDX
$123.7M
$123.7M
$118.9M
$114.7M
$114.2M
$114.2M
$111.4M
$108.4M